Care Provider AI Regulations 2027: MHRA and CQC Compliance Guide for Algorithm-Based Care Tools, AI & Innovation article by Blue Cactus Digital
BACK TO BLOG

Care Provider AI Regulations 2027: MHRA and CQC Compliance Guide for Algorithm-Based Care Tools

Last updated: 2 October 2026

The landscape of artificial intelligence in health and social care is shifting rapidly, and with it comes a new regulatory framework that care providers need to understand. As we look towards 2027, the interaction between the Medicines and Healthcare products Regulatory Agency (MHRA) and the Care Quality Commission (CQC) in overseeing AI-powered care tools is becoming clearer. If you're a care provider using or planning to use algorithm-based systems, now is the time to get to grips with what compliance will look like.

The regulatory picture for AI in care has been evolving since the MHRA published its software and AI as a medical device change programme, building on the foundations laid by the UK Medical Devices Regulations 2002. Meanwhile, the CQC has been developing its approach to assessing digital care technologies through its existing inspection frameworks. Understanding how these two regulatory bodies work together, and what they expect from you, will be crucial for maintaining compliance whilst harnessing AI's potential to improve care.

Understanding Which AI Tools Fall Under MHRA Regulation

The MHRA's jurisdiction covers AI tools that qualify as medical devices. This means any software that has a medical purpose, such as diagnosing conditions, monitoring vital signs, or informing treatment decisions. For care providers, this often includes remote monitoring systems that alert staff to health deterioration, fall detection algorithms, or tools that analyse patient data to predict health risks.

However, not every piece of technology in your care setting will be a medical device. Administrative scheduling software, general communication tools, or simple reminder systems typically fall outside MHRA regulation. The key question is whether the software is intended to be used for a medical purpose. If you're uncertain about a specific tool, the MHRA provides guidance through its software and AI as a medical device programme, and it's worth seeking clarity before implementation.

For tools that do qualify as medical devices, manufacturers must ensure they meet the relevant regulatory requirements, including risk classification and conformity assessment. As a care provider, you should verify that any AI medical device you use carries the appropriate UKCA marking and that the manufacturer has fulfilled their regulatory obligations.

CQC's Role in AI-Enabled Care Delivery

Whilst the MHRA focuses on the safety and performance of AI as a medical device, the CQC looks at how you use technology within the context of care delivery. Their interest centres on whether AI tools help you provide safe, effective, caring, responsive and well-led services, the five key questions that underpin CQC inspections.

The CQC has been clear that technology, including AI, should enhance rather than replace human judgement in care. During inspections, assessors will want to understand how your staff use AI tools, what training they've received, how you monitor the tools' performance, and what happens when the technology fails or produces unexpected results. They'll also examine whether people using your services understand how AI is being used in their care and whether they've consented appropriately.

Your policies and procedures need to reflect this dual responsibility: ensuring the AI tools themselves are safe and regulated appropriately, whilst also demonstrating that your staff use them in ways that support person-centred care. Documentation is crucial here. You should be able to show clear protocols for AI use, incident reporting processes when things go wrong, and evidence of regular reviews.

Preparing Your Organisation for 2027 Compliance

With regulatory expectations crystallising, care providers should take practical steps now to prepare for the compliance landscape of 2027. Start by conducting an audit of all AI and algorithm-based tools currently in use across your organisation. For each one, determine whether it qualifies as a medical device and verify the manufacturer's regulatory status.

Develop clear governance structures around AI use. This means establishing who is accountable for decisions about AI procurement, implementation and monitoring. Many organisations are creating digital technology or AI steering groups that bring together clinical, care, IT and governance expertise. These groups can oversee AI strategy whilst ensuring compliance requirements are met.

Free guide: The Ultimate Guide to Marketing Care Technology

Get the full playbook as a free PDF, no fluff.

Training is another critical element. Your staff need to understand both how to use AI tools effectively and their limitations. They should know when to trust an algorithm's output and when to question it. This is particularly important in care settings where AI might inform decisions about vulnerable people's wellbeing. Consider creating competency frameworks that set out the knowledge and skills staff need when working with specific AI systems.

At Blue Cactus Digital, we've worked with care organisations navigating the implementation of digital tools, and we've seen how important it is to embed compliance thinking from the start rather than treating it as an afterthought. Building relationships with your local CQC inspector and being transparent about your AI use can help demonstrate your commitment to safe, regulated care.

Data Governance and AI Transparency

One area that both regulators take seriously is data governance. AI systems learn from data, and in care settings, that means sensitive personal information about the people you support. You need robust data protection measures that comply with UK GDPR, including clear legal bases for processing, appropriate security measures, and transparent information for service users.

Transparency is particularly important. People receiving care should understand when AI is being used in decisions about their support, what data is being used, and how they can raise concerns. This aligns with both CQC expectations around person-centred care and data protection principles around fair processing.

Consider how you'll explain AI use to people with varying levels of digital literacy or cognitive capacity. Your information materials should be accessible and jargon-free. You should also have clear processes for people to opt out of AI-enabled monitoring or decision support where clinically appropriate, respecting their autonomy whilst managing any risks.

Building a Culture of Responsible AI Use

Beyond regulatory compliance, the most successful care organisations are those that embed responsible AI use into their culture. This means encouraging staff to speak up when AI tools aren't working as expected, regularly reviewing outcomes data to check for bias or unintended consequences, and maintaining a healthy scepticism about technology's promises.

Involve the people who use your services in decisions about AI implementation. Their insights about what works and what feels intrusive or unhelpful are invaluable. Some care providers are establishing service user panels specifically to review digital tools and AI proposals, ensuring that innovation serves real needs rather than pursuing technology for its own sake.

The regulatory framework developing towards 2027 reflects a maturing understanding of AI's role in care. It acknowledges AI's potential whilst ensuring appropriate safeguards. For care providers, this means more clarity about expectations but also more responsibility. The organisations that will thrive are those that see compliance not as a burden but as a framework for delivering better, safer care.

As regulatory requirements continue to evolve, staying informed will be essential. Blue Cactus Digital works specifically with health and social care organisations to navigate the digital landscape, bringing together our understanding of both technology and sector-specific requirements. Whether you're just beginning to explore AI tools or you're managing a portfolio of algorithm-based systems, building compliance into your approach from the outset will serve you well.

Conclusion

The AI regulations care providers face in 2027 will require careful attention to both product regulation through the MHRA and care delivery standards through the CQC. By understanding your obligations now, building strong governance structures, investing in staff training, and maintaining transparency with the people you support, you can position your organisation to use AI responsibly and compliantly. The regulatory landscape may be complex, but it's ultimately designed to ensure that innovation in care happens safely, with people's wellbeing at its heart.

Sources

1. Medicines and Healthcare products Regulatory Agency (MHRA): Software and AI as a Medical Device Change Programme - https://www.gov.uk/government/publications/software-and-ai-as-a-medical-device-change-programme

2. Care Quality Commission: Guidance for providers on meeting the regulations - https://www.cqc.org.uk/guidance-providers/regulations-enforcement

3. UK Government: UK Medical Devices Regulations 2002 - https://www.legislation.gov.uk/uksi/2002/618/contents

4. NHS England: A guide to good practice for digital and data-driven health technologies - https://www.england.nhs.uk/publication/a-guide-to-good-practice-for-digital-and-data-driven-health-technologies/

Free guide

The Ultimate Guide to Marketing Care Technology

Grab the full playbook as a free PDF while you're here.

How healthy is your marketing?

Take our free 60-second marketing health check.

GET MY FREE SCORE

Marketing tips for the sector

Join our newsletter for practical health, care and charity marketing advice. No spam, unsubscribe anytime.